RegiSeed is a new technology that enables intraoperative dosimetry during prostate brachytherapy cancer treatment in software, using an innovative Registration of Ultrasound and Fluoroscopy (RUF) method.

With RegiSeed, radiation oncologists can measure the dose cloud in relation to prostate boundaries during the seed implantation procedure, using imaging modalities already available in the operating room.

RegiSeed is the result of academic and clinical work conducted by the University of Washington Department of Bioengineering. For more information, please contact:

Ismail B. Tutar Chief Scientist RegiSeed ismail.tutar@regiseed.com.

Jason Thane Business Development RegiSeed jason.thane@regiseed.com.